The UK’s first international prescribing service has launched for medical cannabis patients travelling to the country from overseas.
New findings suggest promise for CBN in treating neurological disorders like traumatic brain injury, Alzheimer’s disease, and Parkinson’s disease.
Researchers evaluated the effect of recreational cannabis legalisation and retail sales on use of cannabis, tobacco, and alcohol.
The #ReleaseMyMeds campaign aims to provide support for those patients prescribed medicinal cannabis in the UK.
Following the landmark legislative change in Germany earlier this month, experts are expecting to see a ripple effect across the continent.
The founder of the International Alliance for Cannabinoid Medicine (IACM) on finding a new purpose following his own personal health struggles.
Researchers analysed data from 4,744 US adults aged 45 and older.
A crowdfunder aims to raise £20,000 to undertake public relations and promotional activity around the existence and benefits of prescription cannabis.
Researchers have highlighted the need for greater public health messaging around the risks of cannabis use disorders.
The move will enable individuals with conditions such as anxiety, ADHD or PTSD to access treatment through Treat It clinic.